Levetiracetam Morningside Healthcare

Levetiracetam, the active ingredient in Levetiracetam Morningside Healthcare, is an antiepileptic presented as an oral tablet for oral use. It works by modulating neuronal excitability and is prescribed to manage partial, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy.

GNH USA supplies Levetiracetam Morningside Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets and providing reliable logistics for global distribution.

Levetiracetam is used in the treatment of epilepsy and related seizure disorders.

- Partial seizures: Reduces frequency and severity of focal onset seizures. - Generalized tonic‑clonic seizures: Controls convulsive episodes in generalized epilepsy. - Myoclonic seizures: Decreases sudden muscle jerks associated with myoclonic epilepsy. - Primary generalized seizures: Provides broad seizure control across multiple seizure types.

Levetiracetam may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dizziness: Sensation of light‑headedness or unsteadiness. - Fatigue: General feeling of tiredness. - Headache: Mild to moderate cranial pain. - Irritability: Mood changes or increased agitation. - Nausea: Stomach discomfort or urge to vomit.

Serious or Rare Side Effects: - Severe allergic reaction: Rash, swelling, or difficulty breathing. - Mood or behavior changes: Depression, suicidal thoughts, or aggression. - Hematologic abnormalities: Low blood cell counts. - Multiorgan hypersensitivity: Liver or kidney dysfunction.

When prescribing or dispensing levetiracetam, consider the following precautions to ensure safe use.

- Renal impairment: Adjust dose based on kidney function and monitor creatinine clearance. - Psychiatric history: Observe for mood swings, depression, or suicidal ideation. - Concomitant CNS depressants: Use caution as combined effects may increase sedation. - Pregnancy: Evaluate risk‑benefit ratio; limited data are available. - Lactation: Assess infant exposure through breast milk and consider alternatives. - Store at ambient temperature: Keep below 25 °C in the original container, protected from moisture and light.

Levetiracetam can interact with other medicines; awareness of the interaction level guides clinical decisions.

Major Interactions (Avoid): - Carbamazepine: May reduce levetiracetam plasma concentrations. - Phenytoin: Potential to lower levetiracetam exposure. - Phenobarbital: Can decrease levetiracetam levels.

Moderate Interactions (Monitor Closely): - Valproic acid: May increase levetiracetam concentrations modestly. - Rifampin: Can enhance clearance of levetiracetam. - Oral contraceptives: May experience reduced efficacy; monitor menstrual cycles.